On June 27, 2019, Health Canada published Drug and medical device highlights 2018: Helping you maintain and improve your health, an annual highlights report for 2018. The report provides information regarding Health Canada drug (human or veterinary use) and medical device approvals, as well as published safety issues in 2018. In summary, in 2018, Health Canada approved 78 new drugs for human use (40 involving new active substances), 135 new generic drugs, and 4 biosimilars.
Moreover, the Therapeutic Products Directorate (TPD) and the Biologics and Genetic Therapies Directorate (BGTD) released their Drug Submission Performance Annual Reports for the 2018-2019 Fiscal Year, which include information and statistics relating to drug submission review activity from April 1, 2018 to March 31, 2019.
Related Publications & Articles
-
Medical Devices updates: Annual performance report, new guiding principles for PCCPs for machine learning-enabled medical devices, and regulatory enrolment processes
Explore the latest updates in the field of medical devices, including Health Canada's recently published annual report detailing metrics on the timeliness of pre-market medical device reviews.Read More -
Federal Court finds no procedural unfairness in Minister of Health’s decision that smoking cessation aid not a natural health product
On November 2, 2023, the Federal Court dismissed The Winning Combination (TWC)’s application for judicial review of Health Canada’s decision to refuse a natural health product licence for RESOLVE, a s...Read More -
Federal Court of Appeal dismisses appeal relating to Minister of Health’s decision to disclose records pursuant to Access to Information Act request
On November 1, 2023, the Federal Court of Appeal (FCA) dismissed Actial’s appeal from an application for judicial review of the Minister of Health’s decision to disclose records pursuant to a request...Read More